HI everybody -- I got an email the other day with this update from Zhittay Genesis Medicine's YouTube recent live webinar. From those of you who have been following the progress development of FGF1 -- you know it is inhaled through the nose... no surgery!
-----------------------------------------------------------------------------------------------------
Zhittya Medicine reports:
"To summarize, by the end of August 2022, we project that approximately twenty (20) people will have been administered nose-to-brain FGF-1. As of August 17th, there have been no reported adverse events related to the FGF-1 medicine."
"As reported previously, two of the May 2022 Parkinson’s disease test subjects had a 50% improvement in their motor skill scores. One of these test subjects had her motor skill improvements confirmed by her physical therapist after she returned home."
----------------------------------------------------------------------------------------------------------